Hyaluronic acid-b-polylactic acid polymersomes facilitate CD44-mediated delivery of doxorubicin to glioblastoma in vitro.

Chaudhri A, Garifo M, Thatavarthi P, Fletcher T Jr, Larsen J

Open source

DOI
10.1039/d6pm00188b
Published
2026 Sep 15
Container
RSC pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1039/d6pm00188b,
  title = {Hyaluronic acid-b-polylactic acid polymersomes facilitate CD44-mediated delivery of doxorubicin to glioblastoma in vitro.},
  author = {Chaudhri A and Garifo M and Thatavarthi P and Fletcher T Jr and Larsen J},
  year = {2026},
  journal = {RSC pharmaceutics},
  doi = {10.1039/d6pm00188b},
  url = {https://doi.org/10.1039/d6pm00188b}
}

RIS

TY  - JOUR
TI  - Hyaluronic acid-b-polylactic acid polymersomes facilitate CD44-mediated delivery of doxorubicin to glioblastoma in vitro.
AU  - Chaudhri A
AU  - Garifo M
AU  - Thatavarthi P
AU  - Fletcher T Jr
AU  - Larsen J
PY  - 2026
JO  - RSC pharmaceutics
DO  - 10.1039/d6pm00188b
UR  - https://doi.org/10.1039/d6pm00188b
ER  - 

APA

A, C., M, G., P, T., Jr, F. T., & J, L. (2026). Hyaluronic acid-b-polylactic acid polymersomes facilitate CD44-mediated delivery of doxorubicin to glioblastoma in vitro.. RSC pharmaceutics. https://doi.org/10.1039/d6pm00188b

Source records